Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Both GLP-1 receptor agonists and SGLT2 inhibitors linked to reduced risk for ADRD, with no significant difference between them.

Learn about the impact of Alzheimer's family history on brain resilience and memory function. Your family tree may shape your ...

In the fight against diseases like Alzheimer’s and Parkinson’s, scientists have long struggled to predict how certain proteins misfold. These misfolded proteins, known as amyloids, clump together in ...

New research suggests that calming the brain's immune cells might prevent or lessen the damaging inflammation seen in ...

RIKEN researchers have demonstrated the protective effects of a specific genetic mutation against Alzheimer's disease in ...

The harrowing detail was spotted amongst a trove of pictures released following the deaths of Gene Hackman, 95, his wife ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

A discovery made by authorities in Gene Hackman and wife Betsy Arakawa's home indicates that one of them may have suffered a ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.